Rajendra P. Bandari

Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer

Rajendra P. Bandari, Zongrun Jiang, T. Reynolds et al. · Nuclear Medicine and Biology · 2014 · 57 citations

Medicine, Oncology, Pharmacology +17

A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors

Kübra Durkan, Zongrun Jiang, Tammy L. Rold et al. · Nuclear Medicine and Biology · 2013 · 40 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +14

Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer

Nilantha Bandara, T. Reynolds, Rebecca Schehr et al. · Nuclear Medicine and Biology · 2018 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMA

Rajendra P. Bandari, Terry Carmack, Anil K. Malhotra et al. · Journal of Medicinal Chemistry · 2021 · 24 citations

Medicine, Oncology, Pharmacology +17

Design, Synthesis, and in Vitro and in Vivo Evaluation of High Affinity and Specificity Near-Infrared Fluorescent Bombesin Antagonists for Tumor Imaging

Hang Xu, Rajendra P. Bandari, Li Lee et al. · Journal of Medicinal Chemistry · 2018 · 18 citations

Medicine, Oncology, Pharmacology +17